Safety and Tolerability of BHV-7000, a Novel Kv7 Potassium Channel Activator: Results from Phase 1 Single and Multiple Ascending Dose Studies

Authors
Category Primary study
JournalNeurotherapeutics
Year 2024
This article has no abstract
Epistemonikos ID: 498b36d4f4bc34a138cd51ff703ff89fa65e6799
First added on: Feb 19, 2025